Immune checkpoint inhibitor (ICI) therapies used to treat cancer come with the risk of adverse autoimmune responses, including arthritis that can persist for years and require joint replacement surgery.
from News Medical Medical Research News Feed https://ift.tt/0zKiC9Y
0 Comments